22nd Century Group, Inc. (NASDAQ:XXII – Get Free Report) was the recipient of a significant decline in short interest in the month of November. As of November 15th, there was short interest totalling 243,900 shares, a decline of 88.1% from the October 31st total of 2,050,000 shares. Based on an average daily volume of 8,720,000 shares, the days-to-cover ratio is presently 0.0 days. Approximately 0.6% of the shares of the company are sold short.
Wall Street Analyst Weigh In
Separately, StockNews.com assumed coverage on shares of 22nd Century Group in a research report on Monday. They issued a “sell” rating on the stock.
Read Our Latest Stock Analysis on 22nd Century Group
22nd Century Group Stock Performance
22nd Century Group (NASDAQ:XXII – Get Free Report) last posted its earnings results on Tuesday, November 12th. The biotechnology company reported ($0.54) earnings per share for the quarter. 22nd Century Group had a negative return on equity of 380.39% and a negative net margin of 144.09%. The firm had revenue of $5.95 million for the quarter.
Institutional Investors Weigh In On 22nd Century Group
A hedge fund recently bought a new stake in 22nd Century Group stock. Anson Funds Management LP bought a new stake in 22nd Century Group, Inc. (NASDAQ:XXII – Free Report) in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund bought 3,140,452 shares of the biotechnology company’s stock, valued at approximately $691,000. Anson Funds Management LP owned approximately 6.77% of 22nd Century Group at the end of the most recent quarter. Hedge funds and other institutional investors own 18.06% of the company’s stock.
22nd Century Group Company Profile
22nd Century Group, Inc, a tobacco products company, engages in the sale and distribution of its own proprietary new reduced nicotine tobacco products. The company offers reduced nicotine content tobacco plants and very low nicotine combustible cigarette products. It also provides contract manufacturing services for conventional combustible tobacco products for third-party brands.
See Also
- Five stocks we like better than 22nd Century Group
- Top Stocks Investing in 5G Technology
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- The 3 Best Fintech Stocks to Buy Now
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- How to Calculate Stock Profit
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for 22nd Century Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 22nd Century Group and related companies with MarketBeat.com's FREE daily email newsletter.